Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
13°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fusion Pharmaceuticals Inc
(NQ:
FUSN
)
21.30
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
21.30
Bid (Size)
21.10 (11)
Ask (Size)
21.40 (1)
Prev. Close
21.30
Today's Range
21.30 - 21.30
52wk Range
2.310 - 21.44
Shares Outstanding
63,846,009
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
March 25, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023
March 20, 2024
FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
+157.25%
+157.25%
1 Month
+68.38%
+68.38%
3 Month
+134.58%
+134.58%
6 Month
+776.54%
+776.54%
1 Year
+457.59%
+457.59%
More News
Read More
Recap: Fusion Pharmaceuticals Q4 Earnings
March 20, 2024
Via
Benzinga
Unveiling 11 Analyst Insights On Fusion Pharmaceuticals
March 20, 2024
Via
Benzinga
Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm
March 19, 2024
Via
News Direct
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
March 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –
March 19, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning
March 19, 2024
Via
Investor Brand Network
Nasdaq Down 100 Points; US Housing Starts Surge In February
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
Via
Benzinga
Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover
March 19, 2024
Via
Investor's Business Daily
Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today?
March 19, 2024
Via
InvestorPlace
Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
March 19, 2024
Via
Benzinga
Why Is Ontrak (OTRK) Stock Up 105% Today?
March 19, 2024
Via
InvestorPlace
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
March 19, 2024
Via
Benzinga
Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today?
March 19, 2024
Via
InvestorPlace
US Stocks Poised For Lower Open As Fed Jitters Dampen Tech Hopes; Oil Rally Pauses, Bitcoin Slides 8%
March 19, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 19, 2024
Via
InvestorPlace
FUSN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Fusion Pharmaceuticals Inc. Is Fair to Shareholders
March 19, 2024
From
Halper Sadeh LLC
Via
Business Wire
AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments
March 19, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.